Surfacer ® system has been listed in the United States, provide treatment options for vein occlusion

Merit Medical ® is committed to provide patients with better dialysis path choice of products.The latest is innovationSurfacer ® duct system Inside - Out ®, which is a unique device, designed to get the right side of the center venous pathways vein occlusion patients.Surfacer System earlier this year in the United States won the FDA De Novo classification, and got the CE mark in Europe since 2016.

At present in the treatment of patients with chronic block central venous dialysis method is that if need follow-up central venous catheter, use another vein.Venous access attempts may permanently hinder the establishment of arteriovenous access, so can increase the incidence of patients and overall nursing cost.¹

Central venous pathway, Surfacer system aims to get its working principle is the instrument inserted into the right femoral vein, and up through the in patients with venous system navigation, exit point is located in the right internal jugular vein, this is the best location of central venous catheter placement.Watch the Surfacer working principle of the system.

This exclusive "Inside - Out" method of support to achieve permanent arteriovenous access, and by reducing the incidence of catheter related complications, reduce the cost of hemodialysis performer and waiting time of patients.¹

Human studies have seen for the first time in its use Surfacer systems of other clinical benefit.²Results showed that 100% of patients were successful in central venous access, 100% of the patients with long-term follow-up remain central venous channel unobstructed.In the short or long term follow-up report adverse events associated with the equipment.To learn about Surfacer System for the first time human studies for more information, please check inToday's blood vessels (In English)In the article.

In may this year, Surfacer System first business case in SAN jose, California in the United States of the Santa Clara valley medical center, the center is the survey device exemption (IDE) one of the few clinical study locations, this led to the FDADe NovoState.M.d., Ph.D., Ehab Sorial and md, Ajit Nair on two patients with central venous obstruction of hemodialysis patients underwent surgery, one of the patients with access options are limited.

"Surfacer system provides us with a safe and effective choice, we can get on the right side of central venous pathway in patients with venous congestion, enable us to retain central venous and avoid secondary alternative pathways in operation, the operating efficiency is not high, and have a higher risk of complications," Sorial and Nair, m.d., Ph.D., explained in a press release.Read the full press release here.

Merit distribution Surfacer System currently in North America and Europe.As the equipment has recently launched in the us, Merit to provide life-saving technology for doctors from all over the world, we are very proud to play an indispensable role in this.

exploreSurfacer Inside - Out pathways duct systemAnd explore MeritKidney therapy and accessoriesAll of the product portfolio.